Used primarily in oncology, this compound functions as a multi-targeted tyrosine kinase inhibitor. It interferes with the signaling pathways that promote tumor growth and angiogenesis, making it effective in treating certain types of cancer. It is commonly prescribed for advanced renal cell carcinoma and gastrointestinal stromal tumors that cannot be surgically removed or have metastasized. The compound helps slow tumor progression by inhibiting receptors involved in cell proliferation and blood vessel formation, such as VEGF and PDGF receptors. Its oral formulation allows for convenient outpatient treatment, and it is often used after disease progression on other therapies.